Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Narayan

Showing results (341-350 of 351) with videos related to

Pageof 36
Sort By:
Experimental Dermatology|November 10, 2021
IFN-γ-induced PD-L1 expression on human melanocytes is impaired in vitiligoMarcella Willemsen, Gabrielle Krebbers, Esther P M Tjin, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2025
<i>APOE</i> genotypes differentially remodel the astrocytic lipid droplet-associated proteome to shape lipid droplet dynamicsCarla Cuní-López, Jessica T Root, Ying Hao, et al.
Oncotarget|May 28, 2015
NF-κB drives acquired resistance to a novel mutant-selective EGFR inhibitorElena Galvani, Jing Sun, Leticia G Leon, et al.
Journal of Neuro-Oncology|December 26, 2019
Preclinical evaluation of binimetinib (MEK162) delivered via polymeric nanocarriers in combination with radiation and temozolomide in gliomaFatima Bikhezar, Robin M de Kruijff, Astrid J G M van der Meer, et al.
Neuron|February 22, 2024
Harnessing diversity to study Alzheimer's disease: A new iPSC resource from the NIH CARD and ADNILaurel A Screven, Caroline B Pantazis, Katherine M Andersh, et al.
Cell Reports|July 11, 2025
Triglyceride metabolism controls inflammation and microglial phenotypes associated with APOE4Roxan A Stephenson, Jordy Sepulveda, Kory R Johnson, et al.
Molecular Cancer Therapeutics|September 30, 2017
Identification of MEK162 as a Radiosensitizer for the Treatment of GlioblastomaRavi S Narayan, Ana Gasol, Paul L G Slangen, et al.
Neurobiology of Disease|January 26, 2018
Alpha galactosidase A activity in Parkinson's diseaseR N Alcalay, P Wolf, O A Levy, et al.
Journal of Neuromuscular Diseases|February 6, 2022
Adult North Star Network (ANSN): Consensus Document for Therapists Working with Adults with Duchenne Muscular Dystrophy (DMD) - Therapy GuidelinesS Narayan, A Pietrusz, J Allen, et al.
Nature Communications|June 12, 2020
A cancer drug atlas enables synergistic targeting of independent drug vulnerabilitiesRavi S Narayan, Piet Molenaar, Jian Teng, et al.
Pageof 36

Showing results (341-350 of 351) with videos related to

Sort By:
Pageof 36
Experimental Dermatology|November 10, 2021
IFN-γ-induced PD-L1 expression on human melanocytes is impaired in vitiligoMarcella Willemsen, Gabrielle Krebbers, Esther P M Tjin, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2025
<i>APOE</i> genotypes differentially remodel the astrocytic lipid droplet-associated proteome to shape lipid droplet dynamicsCarla Cuní-López, Jessica T Root, Ying Hao, et al.
Oncotarget|May 28, 2015
NF-κB drives acquired resistance to a novel mutant-selective EGFR inhibitorElena Galvani, Jing Sun, Leticia G Leon, et al.
Journal of Neuro-Oncology|December 26, 2019
Preclinical evaluation of binimetinib (MEK162) delivered via polymeric nanocarriers in combination with radiation and temozolomide in gliomaFatima Bikhezar, Robin M de Kruijff, Astrid J G M van der Meer, et al.
Neuron|February 22, 2024
Harnessing diversity to study Alzheimer's disease: A new iPSC resource from the NIH CARD and ADNILaurel A Screven, Caroline B Pantazis, Katherine M Andersh, et al.
Cell Reports|July 11, 2025
Triglyceride metabolism controls inflammation and microglial phenotypes associated with APOE4Roxan A Stephenson, Jordy Sepulveda, Kory R Johnson, et al.
Molecular Cancer Therapeutics|September 30, 2017
Identification of MEK162 as a Radiosensitizer for the Treatment of GlioblastomaRavi S Narayan, Ana Gasol, Paul L G Slangen, et al.
Neurobiology of Disease|January 26, 2018
Alpha galactosidase A activity in Parkinson's diseaseR N Alcalay, P Wolf, O A Levy, et al.
Journal of Neuromuscular Diseases|February 6, 2022
Adult North Star Network (ANSN): Consensus Document for Therapists Working with Adults with Duchenne Muscular Dystrophy (DMD) - Therapy GuidelinesS Narayan, A Pietrusz, J Allen, et al.
Nature Communications|June 12, 2020
A cancer drug atlas enables synergistic targeting of independent drug vulnerabilitiesRavi S Narayan, Piet Molenaar, Jian Teng, et al.
Pageof 36